This is the authors' abstract. We don't add key points for this paper.
Artificial intelligence (AI) has moved from a topic of academic curiosity to a structural component of neurosurgical research and, increasingly, of clinical workflows. Less than a decade after the first systematic reviews compared machine learning models against the judgement of expert neurosurgeons (1), the scope of inquiry has broadened from isolated proof-of-concept algorithms to multimodal, patient-facing systems spanning the entire surgical journey. The twelve contributions gathered in this Research Topic reflect that broadening: they originate from centers across Asia, Europe, Africa, and North America, draw on data ranging from national administrative registries to intraoperative flow cytometry and smartphone sensors, and together sketch a field that is maturing methodologically while still confronting the translational hurdles that separate a validated model from a trusted clinical tool.A first cluster of contributions concerns image-based diagnosis and lesion characterization, an area benchmarked against multi-institutional efforts like the Brain Tumor Segmentation (BraTS) challenges and spanning preoperative segmentation, postoperative tumor-burden quantification, PET analysis, and synthetic image generation. Deep-learning pipelines have been validated for pre and postoperative brain tumor segmentation,(2,3) extended to meningioma and metastasis via metatransfer learning(4), applied to PET delineation (5) Read together, these contributions suggest that the next phase of AI in neurosurgery will be defined 102 less by isolated algorithmic breakthroughs than by the field's ability to validate models across 103 institutions and populations, make their reasoning legible to clinicians and regulators, and favor low-104 cost, widely accessible solutions that integrate into everyday practice rather than specialized research 105 centers alone. Prospective, multicenter registries; federated learning frameworks that let models learn 106 across hospitals without centralizing sensitive data; and closer collaboration between neurosurgeons, 107 data scientists, and regulators stand out as concrete opportunities ahead. We hope this Research 108 Topic offers both a snapshot of where the field stands today and a useful map for the work that lies 109 ahead, and we thank the authors and reviewers whose contributions made it possible. 110
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bianconi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: